Search
    Menu
    Charles River Laboratories Completes the Acquisition of Cognate BioServices

    Charles River Laboratories Completes the Acquisition of Cognate BioServices

    WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed...

    Find Out More
    Charles River Laboratories Completes the Acquisition of Cognate BioServices
    INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development

    INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development

    Thomas Moore, Science and Medical Correspondent Sky News, is joined by Prof. Lindy Durrant, immunologist and joint CEO/CSO of Scancell, and Alex...

    Find Out More
    INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development
    Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

    Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

    Providing large scale manufacturing capacity for AZD1222

    Find Out More
    Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

    Our Awards

    Breaking the Mould Company of the Year 2020
    QE
    BioNow
    CMO
    CMO
    CMO
    SCB Awards 2017
    TS Business Awards

    Get In Touch

    Speak to a member of our expert Advanced Therapies team.

    Request a Callback
    Get In Touch

    About Cobra Biologics

    Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.

    2 GMP approved facilities
    320+ products released for clinical trials
    20+ Countries serviced